About VA Greater LA Healthcare Systems
Services Offered
Type of Care:
Substance use treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Hospital inpatient/24-hour hospital inpatient Outpatient Residential/24-hour residential Hospital inpatient treatment Intensive outpatient treatment Outpatient methadone/buprenorphine or naltrexone treatment Regular outpatient treatment Long-term residential Short-term residential
Opioid Medications used in Treatment:
Methadone used in Treatment Buprenorphine used in Treatment Naltrexone used in Treatment
Type of Alcohol Use Disorder Treatment:
This facility administers/prescribes medication for alcohol use disorder
External Source of Medications Used for Alcohol Use Disorder Treatment:
In-network prescribing entity
Type of Opioid Treatment:
Buprenorphine maintenance Federally-certified Opioid Treatment Program Methadone maintenance Prescribes buprenorphine Prescribes naltrexone Relapse prevention with naltrexone Lofexidine or Clonidine detoxification Maintenance service with medically supervised withdrawal after stabilization
Pharmacotherapies:
Acamprosate (Campral®) Disulfiram Methadone Buprenorphine with naloxone Buprenorphine without naloxone Buprenorphine (extended-release, injectable) Naltrexone (oral) Naltrexone (extended-release, injectable) Medications for HIV treatment Lofexidine Clonidine Medication for mental disorders Medications for pre-exposure to prophylaxis Nicotine replacement Non-nicotine smoking/tobacco cessation
Treatment Approaches:
Brief intervention Cognitive behavioral therapy Contingency management/motivational incentives Motivational interviewing Matrix Model Relapse prevention Substance use disorder counseling Trauma-related counseling Telemedicine/telehealth therapy 12-step facilitation
Facility Operation (e.g., Private, Public):
Federal Government U.S. Department of Veterans Affairs
License/Certification/Accreditation:
The Joint Commission SAMHSA certification for opioid treatment program (OTP) Drug Enforcement Agency (DEA)
Special Programs/Groups Offered:
Adult women Pregnant/postpartum women Veterans Active duty military Members of military families Clients with co-occurring mental and substance use disorders
Assessment/Pre-treatment:
Comprehensive mental health assessment Comprehensive substance use assessment Interim services for clients Complete medical history/physical exam Screening for tobacco use Screening for substance use Screening for mental disorders
Testing:
Breathalyzer or blood alcohol testing Drug or alcohol urine screening HIV testing STD testing TB screening Metabolic syndrome monitoring Testing for Hepatitis B (HBV) Testing for Hepatitis C (HCV)
Transitional Services:
Aftercare/continuing care Discharge Planning Naloxone and overdose education Outcome follow-up after discharge
Recovery Support Services:
Housing services Assistance with obtaining social services Recovery coach Mentoring/peer support Employment counseling or training
Other Services:
Treatment for gambling disorder Treatment for other addiction disorder
Education and Counseling Services:
Substance use disorder education Smoking/vaping/tobacco cessation counseling Individual counseling Group counseling
Medical Services:
Hepatitis A (HAV) vaccination Hepatitis B (HBV) vaccination
Facility Smoking Policy :
Smoking permitted in designated area
Age Groups Accepted:
Young Adults Adults
Sex Accepted:
Female Male
Facility Vaping Policy:
Vaping permitted in designated area
Ancillary Services:
Case management service Domestic violence services, including family or partner Mental health services Social skills development Transportation assistance Suicide prevention services
Payment/Insurance/Funding Accepted
Federal, or any government funding for substance use treatment programs
